These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31585803)

  • 41. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.
    Montalvo I; Ortega L; López X; Solé M; Monseny R; Franch J; Vilella E; Labad J
    Int Clin Psychopharmacol; 2013 Jan; 28(1):46-9. PubMed ID: 23232756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sexual behaviour in schizophrenic patients: the impact of antipsychotics].
    Tardieu S; Micallef J; Bonierbale M; Frauger E; Lançon C; Blin O
    Encephale; 2006 Oct; 32(5 Pt 1):697-704. PubMed ID: 17099593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interventions for sexual dysfunction following treatments for cancer.
    Miles CL; Candy B; Jones L; Williams R; Tookman A; King M
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005540. PubMed ID: 17943864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperprolactinemia and medications for bipolar disorder: systematic review of a neglected issue in clinical practice.
    Pacchiarotti I; Murru A; Kotzalidis GD; Bonnin CM; Mazzarini L; Colom F; Vieta E
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1045-59. PubMed ID: 25937241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperprolactinemia associated with psychotropics--a review.
    Madhusoodanan S; Parida S; Jimenez C
    Hum Psychopharmacol; 2010; 25(4):281-97. PubMed ID: 20521318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy and tolerance of PDE-5 in the treatment of erectile dysfunction in schizophrenic patients: A literature review].
    Bacconi L; Gressier F
    Encephale; 2017 Feb; 43(1):55-61. PubMed ID: 27658991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review.
    Wieck A; Haddad PM
    Br J Psychiatry; 2003 Mar; 182():199-204. PubMed ID: 12611781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics.
    La Torre A; Conca A; Duffy D; Giupponi G; Pompili M; Grözinger M
    Pharmacopsychiatry; 2013 Sep; 46(6):201-8. PubMed ID: 23737244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sexual dysfunction in patients treated with atypical antipsychotics.
    Meyer JM
    J Clin Psychiatry; 2008 Sep; 69(9):e26. PubMed ID: 19026271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings.
    de Boer MK; Castelein S; Wiersma D; Schoevers RA; Knegtering H
    Schizophr Bull; 2015 May; 41(3):674-86. PubMed ID: 25721311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
    Byerly M; Suppes T; Tran QV; Baker RA
    J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sexual side-effects of antidepressant and antipsychotic drugs.
    Montejo AL; Montejo L; Navarro-Cremades F
    Curr Opin Psychiatry; 2015 Nov; 28(6):418-23. PubMed ID: 26382168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Systematic Review on Mindfulness Meditation-Based Interventions for Sexual Dysfunctions.
    Jaderek I; Lew-Starowicz M
    J Sex Med; 2019 Oct; 16(10):1581-1596. PubMed ID: 31570137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erectile Dysfunction: An Umbrella Review of Meta-Analyses of Risk-Factors, Treatment, and Prevalence Outcomes.
    Allen MS; Walter EE
    J Sex Med; 2019 Apr; 16(4):531-541. PubMed ID: 30833150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole.
    De Berardis D; Fornaro M; Serroni N; Marini S; Piersanti M; Cavuto M; Valchera A; Mazza M; Girinelli G; Iasevoli F; Perna G; Martinotti G; Di Giannantonio M
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):30-7. PubMed ID: 24372345
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.